Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time, scientists can explore a comprehensive map of more than 9 billion possible single-letter DNA changes KEY HIGHLIGHTS Developed over several years, AlphaGenome Atlas is a one-petabyte dataset containing molecular-effect predictions for more than […]

Certified and integrated ecosystem within BC Mosaic helps healthcare and life sciences teams accelerate research and innovation by bringing specialized tools into BC Platforms’ industry-leading trusted research environment BC Platforms today announced the launch of the BC Mosaic App Store, a certified ecosystem of specialized analytical and research applications. Through the BC Mosaic App Store, […]

Nasdaq First North-listed Qlucore, a leading provider of software for data analysis and precision diagnostics, today announced that it has entered into a reseller agreement with BioTuring, a pioneering bioinformatics software company based in San Diego, USA. Through this collaboration, Qlucore will distribute BioTuring’s software solutions across Europe. BioTuring is a bioinformatics company pioneering computational […]

Collaboration embeds evidence-grounded agentic AI into scientific workflows across Syneos Health, accelerating research while strengthening scientific rigor, consistency, and sponsor value LONDON — Causaly, the agentic AI platform purpose-built for life sciences research and development, today announced a strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization. The collaboration will help establish a […]

Milestone release introduces L7|SYNAPSE™ AI framework, up to 100x performance boost, and advanced NORs & PARs compliance modeling to power mission-critical operations. AUSTIN, Texas — L7 Informatics, Inc., a provider of foundational data orchestration and digital transformation infrastructure for precision sciences, today announced the general availability of L7|ESP 2026.1. Building on a unified composable data […]

Introducing a new AI approach for accelerated biomarker discovery, demonstrated through Alzheimer’s disease biomarker modeling validated in an independent cohort Basel, Switzerland — Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new AI agent in Genedata Profiler®, its enterprise platform for integrating and analyzing data across […]

BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS’s decentralized clinical trial assays and companion […]

New offerings deliver a full biochemome as a $200-per-sample full-service readout or a $25-per-sample subscription/enterprise license to run on a laboratory’s own instruments SOMERVILLE, Mass. — PyxisLabs™, Matterworks, Inc.’s AI Native Laboratory for scalable biochemical omics and predictive biology, today announces two commercial offerings: biochemical analysis services and enterprise subscription licenses for quantitative, untargeted biochemical […]

Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]

Lucid Genomics provides in-kind access to its genomic analysis platform for laboratories participating in global undiagnosed disease genomics program. By providing our platform in-kind, we hope to help reduce barriers to genomic diagnostics and support Genetic Alliance’s efforts to expand equitable access for patients with rare diseases.” — Uira Souto Melo, Co-Founder and CEO at […]